Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated [Phase 2]
A Phase 2 study evaluated the effectiveness and tolerability of BI 655130 in patients with atopic dermatitis, with results posted after comp…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) [Phase 2]
Phase 2B study evaluating ASN002 for moderate-to-severe atopic dermatitis has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial of baricitinib in moderate to severe atopic dermatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of etrasimod for moderate-to-severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" [Phase 4]
A Phase 4 trial assessing the effect of Dupixent (dupilumab) on sleep in adults with atopic dermatitis has completed, with results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial update on PROs and caregiver burden in children with atopic dermatitis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus [Phase 2]
Phase 2 randomized trial evaluating Aurstat versus control for pruritus associated with atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis [Phase 2]
Phase 2 study evaluating multiple-dose BLU-5937 for chronic pruritus associated with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2 study of B244 in mild to moderate atopic dermatitis completed, results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients [Phase 2]
Phase 2 trial assessing efficacy and safety of oral DS107 in moderate to severe atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD) [Phase 2]
Phase 2 clinical trial studying safety and efficacy of topically applied DS107 cream in mild to moderate atopic dermatitis; study completed …
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Oral DS107 in Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update for oral DS107 in moderate to severe atopic dermatitis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating BTX 1204 for safety, tolerability, and efficacy in moderate atopic dermatitis has completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating Tralokinumab in combination with topical corticosteroids in Japanese patients with moderate-to-severe Atopic Dermat…
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Lebrikizumab (LY3650150) in moderate to severe atopic dermatitis has completed with post…
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for QY201 Tablet in subjects with moderate to severe atopic dermatitis across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating FMX114 vs vehicle in adults with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) [Phase 3]
Phase 3 trial evaluating lebrikizumab for moderate to severe atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating PF-07038124 ointment for atopic dermatitis and plaque psoriasis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) [Phase 2, Phase 3]
Clinical trial update on safety, pharmacokinetics, and efficacy of dupilumab in children 6 months to under 6 years with moderate-to-severe a…
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis [Phase 3]
Phase 3 trial update reporting efficacy of fecal microbial transplantation for adults with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Dupilumab Skin Barrier Function Study in Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update shows completed study evaluating dupilumab's effect on skin barrier function in atopic dermatitis, with result…
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 trial of TER-101 topical ointment for atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Response of Children With Atopic Dermatitis (Eczema) to Eucrisa [Phase 4]
Phase 4 trial update evaluating response of children with atopic dermatitis (eczema) to Eucrisa.
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis [Phase 1]
Phase 1 safety trial of tezepelumab (AMG 157) in healthy adults and adults with atopic dermatitis has completed with results posted.